CD4 and myeloid sarcoma: Finally, the rs3118470 risk allele (G) is related to a diminished CD56bright NK/IL-17 A+CD4+ T-cell ratio in MS patients, although IL2RA gene expression levels do not correlate with NK/T-cell ratios [81].